George Kemble, Executive Chairman: Sagimet Biosciences SGMT Sell · Filed 24/07/25

Trade details

Type: Insider sale
Amount: $74,891.25
Shares · price: 23,625 sh · $3.17 a share
Held after: 118,693 sh
Stock: Sagimet Biosciences SGMT
Person: George KembleExecutive Chairman
Trade date: 24/07/23
Filed: 24/07/25
Days to filing: 2 days

Sold 16.6% of holdings

Share of holding sold: 16.6%

Sagimet Biosciences trades, last 26 weeks

What else happened in Sagimet Biosciences around then

Filed or reported within 30 days of the trade day · 24/06/23~24/08/22

George Kemble's recent trades

George KembleDirector
Planned sale10b5-1 planSagimet Biosciences
Planned sale10b5-1 plan
Sagimet Biosciences
SGMT
$3.3M
350,987 sh
$3.3M
Filed 08/14
Traded 08/14
George KembleDirector
Planned sale10b5-1 planSagimet Biosciences
Planned sale10b5-1 plan
Sagimet Biosciences
SGMT
$193.4K
20,206 sh
$193.4K
Filed 08/11
Traded 08/11
George KembleDirector
Planned sale10b5-1 planSagimet Biosciences
Planned sale10b5-1 plan
Sagimet Biosciences
SGMT
$147.4K
18,844 sh
$147.4K
Filed 07/20
Traded 07/20
George KembleExecutive Chairman
Sell10b5-1 planSagimet Biosciences
Sell10b5-1 plan
Sagimet Biosciences
SGMT
$289.8K
37,688 sh
$289.8K
Filed 25/11/21
Traded 25/11/20
George KembleDirector
Planned sale10b5-1 planSagimet Biosciences
Planned sale10b5-1 plan
Sagimet Biosciences
SGMT
$295.9K
37,688 sh
$295.9K
Filed 25/11/20
Traded 25/11/20